AngioDynamics, Inc. (ANGO)
15.11
-0.01
(-0.07%)
USD |
NASDAQ |
Oct 02, 16:00
15.12
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics EPS Diluted (Quarterly) : -0.2735 for May 31, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -0.2735 |
| February 28, 2026 | -0.1944 |
| November 30, 2025 | -0.1529 |
| August 31, 2025 | -0.2648 |
| May 31, 2025 | -0.1476 |
| February 28, 2025 | -0.1079 |
| November 30, 2024 | -0.2624 |
| August 31, 2024 | -0.3148 |
| May 31, 2024 | -0.3327 |
| February 29, 2024 | -4.666 |
| November 30, 2023 | -0.7222 |
| August 31, 2023 | 1.148 |
| May 31, 2023 | -0.542 |
| February 28, 2023 | -0.2401 |
| November 30, 2022 | -0.2149 |
| August 31, 2022 | -0.3309 |
| May 31, 2022 | -0.16 |
| February 28, 2022 | -0.1268 |
| November 30, 2021 | -0.2138 |
| August 31, 2021 | -0.18 |
| May 31, 2021 | -0.5053 |
| February 28, 2021 | -0.0924 |
| November 30, 2020 | -0.1114 |
| August 31, 2020 | -0.1118 |
| May 31, 2020 | -4.099 |
| Date | Value |
|---|---|
| February 29, 2020 | -0.1502 |
| November 30, 2019 | -0.072 |
| August 31, 2019 | -0.0338 |
| May 31, 2019 | 1.538 |
| February 28, 2019 | 0.0212 |
| November 30, 2018 | 0.0571 |
| August 31, 2018 | -0.0126 |
| May 31, 2018 | 0.0557 |
| February 28, 2018 | 0.37 |
| November 30, 2017 | 0.01 |
| August 31, 2017 | -0.001 |
| May 31, 2017 | -0.35 |
| February 28, 2017 | 0.08 |
| November 30, 2016 | 0.37 |
| August 31, 2016 | 0.04 |
| May 31, 2016 | -1.20 |
| February 29, 2016 | 0.02 |
| November 30, 2015 | -0.01 |
| August 31, 2015 | -0.02 |
| May 31, 2015 | -0.02 |
| February 28, 2015 | -0.12 |
| November 30, 2014 | 0.04 |
| August 31, 2014 | 0.01 |
| May 31, 2014 | -0.03 |
| February 28, 2014 | 0.14 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.615 |
| Penumbra, Inc. | 0.8797 |
| Abbott Laboratories | 0.5324 |
| Alphatec Holdings, Inc. | -0.1647 |
| AtriCure, Inc. | 0.1832 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.40M |
| Revenue (Quarterly) | 86.61M |
| Total Expenses (Quarterly) | 98.01M |
| Enterprise Value | 587.18M |
| Gross Profit Margin (Quarterly) | 50.87% |
| Profit Margin (Quarterly) | -13.17% |
| Earnings Yield | -5.86% |
| Normalized Earnings Yield | -3.960 |